Investigative studies in the diagnosis and treatment of melanoma.
Journal Article (Journal Article)
Patients with melanoma have prognostic indicators that can be accurately assessed using standard histopathologic techniques. First-order lymph node disease plays a significant role in determining both the prognosis of the patient and the therapeutic benefit in selected patients. The lymph nodes at risk can be determined by the technique of lymphoscintigraphy, and specificity might be possible using isotopically labeled monoclonal antibodies. Techniques utilizing immunohistology and immunocytology have been developed and applied to the clinical setting. Early diagnosis of recurrent disease is now possible using radioimmunoassays. Specific immunotherapy trials are underway and early results are encouraging.
Full Text
Duke Authors
Cited Authors
- Seigler, HF
Published Date
- July 1986
Published In
Volume / Issue
- 21 / 7
Start / End Page
- 596 - 600
PubMed ID
- 3733389
International Standard Serial Number (ISSN)
- 0020-9996
Digital Object Identifier (DOI)
- 10.1097/00004424-198607000-00017
Language
- eng
Conference Location
- United States